Monday, January 25, 2010 3:24:12 PM
"Shares of this development-stage biotechnology company focused on the research, development and licensing of an adult stem cell active compound that in study results has been shown to regenerate and strengthen the immune system and enhance wound healing have been rising steadily the last two sessions on rumors that the U.S. Government has taken a great interest in it's Homspera product and may be awarding some research grants said to be in the tens of millions of dollars."
From Biomedreports.com
Link:
http://biomedreports.com/articles/subscriber-only-content/26070-watchlist-alert-for-stem-cell-compund-co.html
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM